Module

Assessing HBV Virologic Markers

Source: Clinical Strategies for Preventing and Managing Resistance to Anti-HBV Agents

Assessing HBV Virologic Markers

Faculty:
Stephen Locarnini, MD, PhD, FRC (Path)

CME CREDIT INFORMATION

Release Date: 04/14/06

Expiration Date: 04/13/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the use of serum HBV DNA as a marker of disease progression in chronic hepatitis B
Discuss assays for intrahepatic HBV DNA
Review genotyping methods and trends in HBV genotypes

Topics covered include:

Introduction
HBV DNA Testing in Serum
Serum HBV DNA as a Marker for Disease Progression
HBV DNA Testing in the Liver
cccDNA and Nucleos(t)ide Analogues
HBV DNA Genotyping
HBV Mutation Testing

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.